Angiotensin type 1a receptors on corticotropin-releasing factor neurons contribute to the expression of conditioned fear1

Genes, Brain and Behavior

Volumn 14, Issue 7, 2015, Pages 526-533

  Hurt, R C ^a,b   Garrett, J C ^a,b   Keifer, O P ^a,b   Linares, A ^c,d   Couling, L ^d   Speth, R C ^d,e   Ressler, K J ^a,b,f   Marvar, P J ^g  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c Farquhar College of Arts and Sciences   (United States)

^d NOVA SOUTHEASTERN UNIVERSITY   (United States)

^e GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^g GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Amygdala; Angiotensin II; Angiotensin II receptor type 1; Blood pressure; Cardiovascular; Corticotropin releasing factor; Extinction; Fear; Paraventricular nucleus; PTSD

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; CORTICOTROPIN RELEASING FACTOR; AGTR1A PROTEIN, MOUSE; ANGIOTENSIN 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BLOOD PRESSURE; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; FEAR; FREEZING; GENE DELETION; HEART RATE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; LOCOMOTION; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WILD TYPE; ANIMAL; CATALEPSY; CONDITIONED REFLEX; GENETICS; MALE; METABOLISM; PHYSIOLOGY;

ANIMALS; CONDITIONING, CLASSICAL; CORTICOTROPIN-RELEASING HORMONE; FEAR; FREEZING REACTION, CATALEPTIC; MALE; MICE; NEURONS; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 84940789662     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/gbb.12235     Document Type: Article

References (59)

1. Aguilera, G., Kapur, S., Feuillan, P., Sunar-Akbasak, B. & Bathia, A.J. (1994) Developmental changes in angiotensin II receptor subtypes and AT1 receptor mRNA in rat kidney. Kidney Int 46, 973-979.
2. Aguilera, G., Kiss, A. & Luo, X. (1995a) Increased expression of type 1 angiotensin II receptors in the hypothalamic paraventricular nucleus following stress and glucocorticoid administration. J Neuroendocrinol 7, 775-783.
3. Aguilera, G., Young, W.S., Kiss, A. & Bathia, A. (1995b) Direct regulation of hypothalamic corticotropin-releasing-hormone neurons by angiotensin II. Neuroendocrinology 61, 437-444.
4. Armando, I., Volpi, S., Aguilera, G. & Saavedra, J.M. (2007) Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress. Brain Res 1142, 92-99.
5. Bale, T.L., Lee, K.F. & Vale, W.W. (2002) The role of corticotropin-releasing factor receptors in stress and anxiety. Integr Comp Biol 42, 552-555.
6. Beckerman, M.A., Van Kempen, T.A., Justice, N.J., Milner, T.A. & Glass, M.J. (2013) Corticotropin-releasing factor in the mouse central nucleus of the amygdala: ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as projection neurons to the bed nucleus of the stria terminalis. Exp Neurol 239, 120-132.
7. Castrop, H. (2015) A role for AT1 receptor-associated proteins in blood pressure regulation. Curr Opin Pharmacol 21, 43-47.
8. Chen, D. & Coffman, T.M. (2015) AT Angiotensin receptors-vascular and renal epithelial pathways for blood pressure regulation. Curr Opin Pharmacol 21, 122-126.
9. Chen, D., Jancovski, N., Bassi, J.K., Nguyen-Huu, T.P., Choong, Y.T., Palma-Rigo, K., Davern, P.J., Gurley, S.B., Thomas, W.G., Head, G.A. & Allen, A.M. (2012) Angiotensin type 1A receptors in C1 neurons of the rostral ventrolateral medulla modulate the pressor response to aversive stress. J Neurosci 32, 2051-2061.
10. Choi, D.C., Maguschak, K.A., Ye, K., Jang, S.W., Myers, K.M. & Ressler, K.J. (2010) Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear. Proc Natl Acad Sci U S A 107, 2675-2680.
11. Ciccocioppo, R., De Guglielmo, G., Hansson, A.C., Ubaldi, M., Kallupi, M., Cruz, M.T., Oleata, C.S., Heilig, M. & Roberto, M. (2014) Restraint stress alters nociceptin/orphanin FQ and CRF systems in the rat central amygdala: significance for anxiety-like behaviors. J Neurosci 34, 363-372.
12. Frenkel, L., Maldonado, H. & Delorenzi, A. (2005) Memory strengthening by a real-life episode during reconsolidation: an outcome of water deprivation via brain angiotensin II. Eur J Neurosci 22, 1757-1766.
13. Gafford, G.M., Guo, J.D., Flandreau, E.I., Hazra, R., Rainnie, D.G. & Ressler, K.J. (2012) Cell-type specific deletion of GABA(A)alpha1 in corticotropin-releasing factor-containing neurons enhances anxiety and disrupts fear extinction. Proc Natl Acad Sci U S A 109, 16330-16335.
14. Gafford, G., Jasnow, A.M. & Ressler, K.J. (2014) Grin1 receptor deletion within CRF neurons enhances fear memory. PLoS One 9, e111009.
15. Gonzalez, A.D., Wang, G., Waters, E.M., Gonzales, K.L., Speth, R.C., Van Kempen, T.A., Marques-Lopes, J., Young, C.N., Butler, S.D., Davisson, R.L., Iadecola, C., Pickel, V.M., Pierce, J.P. & Milner, T.A. (2012) Distribution of angiotensin type 1a receptor-containing cells in the brains of bacterial artificial chromosome transgenic mice. Neuroscience 226, 489-509.
16. Guo, D.F., Sun, Y.L., Hamet, P. & Inagami, T. (2001) The angiotensin II type 1 receptor and receptor-associated proteins. Cell Res 11, 165-180.
17. Higuchi, S., Ohtsu, H., Suzuki, H., Shirai, H., Frank, G.D. & Eguchi, S. (2007) Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 112, 417-428.
18. Hirawa, N., Uehara, Y., Kawabata, Y., Numabe, A., Gomi, T., Ikeda, T., Suzuki, T., Goto, A., Toyo-Oka, T. & Omata, M. (1999) Long-term inhibition of renin-angiotensin system sustains memory function in aged Dahl rats. Hypertension 34, 496-502.
19. Johnson, P.L., Sajdyk, T.J., Fitz, S.D., Hale, M.W., Lowry, C.A., Hay-Schmidt, A. & Shekhar, A. (2013) Angiotensin II's role in sodium lactate-induced panic-like responses in rats with repeated urocortin 1 injections into the basolateral amygdala: amygdalar angiotensin receptors and panic. Prog Neuropsychopharmacol Biol Psychiatry 44, 248-256.
20. Kerr, D.S., Bevilaqua, L.R., Bonini, J.S., Rossato, J.I., Kohler, C.A., Medina, J.H., Izquierdo, I. & Cammarota, M. (2005) Angiotensin II blocks memory consolidation through an AT2 receptor-dependent mechanism. Psychopharmacology (Berl) 179, 529-535.
21. Khoury, N.M., Marvar, P.J., Gillespie, C.F., Wingo, A., Schwartz, A., Bradley, B., Kramer, M. & Ressler, K.J. (2012) The renin-angiotensin pathway in posttraumatic stress disorder: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms. J Clin Psychiatry 73, 849-855.
22. Kirby, L.G., Rice, K.C. & Valentino, R.J. (2000) Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22, 148-162.
23. Krause, E.G., De Kloet, A.D., Scott, K.A., Flak, J.N., Jones, K., Smeltzer, M.D., Ulrich-Lai, Y.M., Woods, S.C., Wilson, S.P., Reagan, L.P., Herman, J.P. & Sakai, R.R. (2011) Blood-borne angiotensin II acts in the brain to influence behavioral and endocrine responses to psychogenic stress. J Neurosci 31, 15009-15015.
24. Lew, R.A., Mustafa, T., Ye, S., Mcdowall, S.G., Chai, S.Y. & Albiston, A.L. (2003) Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP). J Neurochem 86, 344-350.
25. Marinzalda Mde, L., Perez, P.A., Gargiulo, P.A., Casarsa, B.S., Bregonzio, C. & Baiardi, G. (2014) Fear-potentiated behaviour is modulated by central amygdala angiotensin II AT1 receptors stimulation. Biomed Res Int 2014, 183248.
26. Marques-Lopes, J., Lynch, M.K., Van Kempen, T.A., Waters, E.M., Wang, G., Iadecola, C., Pickel, V.M. & Milner, T.A. (2015) Female protection from slow-pressor effects of angiotensin II involves prevention of ROS production independent of NMDA receptor trafficking in hypothalamic neurons expressing angiotensin 1A receptors. Synapse 69, 148-165.
27. Martin, E.I., Ressler, K.J., Jasnow, A.M., Dabrowska, J., Hazra, R., Rainnie, D.G., Nemeroff, C.B. & Owens, M.J. (2010) A novel transgenic mouse for gene-targeting within cells that express corticotropin-releasing factor. Biol Psychiatry 67, 1212-1216.
28. Marvar, P.J., Thabet, S.R., Guzik, T.J., Lob, H.E., Mccann, L.A., Weyand, C., Gordon, F.J. & Harrison, D.G. (2010) Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res 107, 263-270.
29. Marvar, P.J., Goodman, J., Fuchs, S., Choi, D.C., Banerjee, S. & Ressler, K.J. (2013) Angiotensin type 1 receptor inhibition enhances the extinction of fear memory. Biol Psychiatry 75, 864-872.
30. Mehta, P.K. & Griendling, K.K. (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292, C82-C97.
31. Nylocks, K.M., Michopoulos, V., Rothbaum, A.O., Almli, L., Gillespie, C.F., Wingo, A., Schwartz, A.C., Habib, L., Gamwell, K.L., Marvar, P.J., Bradley, B. & Ressler, K.J. (2015) An angiotensin-converting enzyme (ACE) polymorphism may mitigate the effects of angiotensin-pathway medications on posttraumatic stress symptoms. Am J Med Genet B Neuropsychiatr Genet 168, 307-315.
32. Otagiri, A., Wakabayashi, I. & Shibasaki, T. (2000) Selective corticotropin-releasing factor type 1 receptor antagonist blocks conditioned fear-induced release of noradrenaline in the hypothalamic paraventricular nucleus of rats. J Neuroendocrinol 12, 1022-1026.
33. Pellow, S., Chopin, P., File, S.E. & Briley, M. (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14, 149-167.
34. Pitts, M.W. & Takahashi, L.K. (2011) The central amygdala nucleus via corticotropin-releasing factor is necessary for time-limited consolidation processing but not storage of contextual fear memory. Neurobiol Learn Mem 95, 86-91.
35. Pitts, M.W., Todorovic, C., Blank, T. & Takahashi, L.K. (2009) The central nucleus of the amygdala and corticotropin-releasing factor: insights into contextual fear memory. J Neurosci 29, 7379-7388.
36. Premer, C., Lamondin, C., Mitzey, A., Speth, R.C. & Brownfield, M.S. (2013) Immunohistochemical localization of AT1a, AT1b, and AT2 angiotensin II receptor subtypes in the rat adrenal, pituitary, and brain with a perspective commentary. Int J Hypertens 2013, 175428.
37. Rainnie, D.G., Bergeron, R., Sajdyk, T.J., Patil, M., Gehlert, D.R. & Shekhar, A. (2004) Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J Neurosci 24, 3471-3479.
38. Rateri, D.L., Moorleghen, J.J., Balakrishnan, A., Owens, A.P. 3rd, Howatt, D.A., Subramanian, V., Poduri, A., Charnigo, R., Cassis, L.A. & Daugherty, A. (2011) Endothelial cell-specific deficiency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor-/- mice. Circ Res 108, 574-581.
39. Rivier, C.L. & Plotsky, P.M. (1986) Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion. Annu Rev Physiol 48, 475-494.
40. Saavedra, J.M., Armando, I., Bregonzio, C., Juorio, A., Macova, M., Pavel, J. & Sanchez-Lemus, E. (2006) A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding. Neuropsychopharmacology 31, 1123-1134.
41. Shekhar, A. (2014) Angiotensin type 1 receptor antagonists-a novel approach to augmenting posttraumatic stress disorder and phobia therapies? Biol Psychiatry 75, 836-837.
42. Shekhar, A., Truitt, W., Rainnie, D. & Sajdyk, T. (2005) Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety. Stress 8, 209-219.
43. Shekhar, A., Johnson, P.L., Sajdyk, T.J., Fitz, S.D., Keim, S.R., Kelley, P.E., Gehlert, D.R. & Dimicco, J.A. (2006) Angiotensin-II is a putative neurotransmitter in lactate-induced panic-like responses in rats with disruption of GABAergic inhibition in the dorsomedial hypothalamus. J Neurosci 26, 9205-9215.
44. Sheng, M. & Kim, M.J. (2002) Postsynaptic signaling and plasticity mechanisms. Science 298, 776-780.
45. Sorge, R.E., Martin, L.J., Isbester, K.A. et al. (2014) Olfactory exposure to males, including men, causes stress and related analgesia in rodents. Nat Methods 11, 629-632.
46. Speth, R.C. & Harding, J.W. (2001) Radiolabeling of angiotensin peptides. Methods Mol Med 51, 275-295.
47. Speth, R.C., Barry, W.T., Smith, M.S. & Grove, K.L. (1999) A comparison of brain angiotensin II receptors during lactation and diestrus of the estrous cycle in the rat. Am J Physiol 277, R904-R909.
48. Sternson, S.M. & Roth, B.L. (2014) Chemogenetic tools to interrogate brain functions. Annu Rev Neurosci 37, 387-407.
49. Sullivan, G.M., Apergis, J., Bush, D.E., Johnson, L.R., Hou, M. & Ledoux, J.E. (2004) Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience 128, 7-14.
50. Tatem, K.S., Quinn, J.L., Phadke, A., Yu, Q., Gordish-Dressman, H. & Nagaraju, K. (2014) Behavioral and locomotor measurements using an open field activity monitoring system for skeletal muscle diseases. J Vis Exp, 91, e51785.
51. Tchekalarova, J. & Albrecht, D. (2007) Angiotensin II suppresses long-term depression in the lateral amygdala of mice via L-type calcium channels. Neurosci Lett 415, 68-72.
52. Valentino, R.J., Liouterman, L. & Van Bockstaele, E.J. (2001) Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus. J Comp Neurol 435, 450-463.
53. Von Bohlen Und Halbach, O. & Albrecht, D. (1998a) Angiotensin II inhibits long-term potentiation within the lateral nucleus of the amygdala through AT1 receptors. Peptides 19, 1031-1036.
54. Von Bohlen Und Halbach, O. & Albrecht, D. (1998b) Visualization of specific angiotensin II binding sites in the rat limbic system. Neuropeptides 32, 241-245.
55. Wilensky, A.E., Schafe, G.E., Kristensen, M.P. & Ledoux, J.E. (2006) Rethinking the fear circuit: the central nucleus of the amygdala is required for the acquisition, consolidation, and expression of Pavlovian fear conditioning. J Neurosci 26, 12387-12396.
56. Wright, J.W. & Harding, J.W. (1995) Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functions. Regul Pept 59, 269-295.
57. Wright, J.W., Stubley, L., Pederson, E.S., Kramar, E.A., Hanesworth, J.M. & Harding, J.W. (1999) Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning. J Neurosci 19, 3952-3961.
58. Wright, J.W., Kramar, E.A., Meighan, S.E. & Harding, J.W. (2002) Extracellular matrix molecules, long-term potentiation, memory consolidation and the brain angiotensin system. Peptides 23, 221-246.
59. Yamamoto, R., Akazawa, H., Fujihara, H., Ozasa, Y., Yasuda, N., Ito, K., Kudo, Y., Qin, Y., Ueta, Y. & Komuro, I. (2011) Angiotensin II type 1 receptor signaling regulates feeding behavior through anorexigenic corticotropin-releasing hormone in hypothalamus. J Biol Chem 286, 21458-21465.